ID
41157
Description
Study ID: 103471 Clinical Study ID: 103471 Study Title: A randomised, double blind, placebo-controlled, double dummy, five-way cross over dose-escalation study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of single inhaled doses of GSK233705 (20-500µg via DPI), and, tiotropium bromide (18µg via DPI) in healthy male subjects. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Sponsor: GlaxoSmithKline Phase: Phase 1 Study Recruitment Status: Completed Generic Name: Darotropium Bromide Trade Name: Darotropium Bromide Study Indication: Chronic Obstructive Pulmonary Disease (COPD)
Keywords
Versions (1)
- 7/2/20 7/2/20 -
Copyright Holder
GlaxoSmithKline
Uploaded on
July 2, 2020
DOI
To request one please log in.
License
Creative Commons BY-NC 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Safety, tolerability, pharmacokinetics and pharmacodynamics of GSK233705 and tiotropium bromide (103471)
Physical Examination
- StudyEvent: ODM
Description
Physical Examination
Alias
- UMLS CUI-1
- C0031809
Description
Physical Examination
Alias
- UMLS CUI-1
- C0031809
Description
Physical Examination
Data type
integer
Alias
- UMLS CUI [1]
- C0031809
Description
If ABNORMAL, describe concisely
Data type
integer
Alias
- UMLS CUI [1,1]
- C0031809
- UMLS CUI [1,2]
- C0243095
Description
Physical examination abnormal finding description
Data type
text
Alias
- UMLS CUI [1,1]
- C2826636
- UMLS CUI [1,2]
- C0678257
Similar models
Physical Examination
- StudyEvent: ODM
C0243095 (UMLS CUI [1,2])
C0678257 (UMLS CUI [1,2])
No comments